Kevin O'Connor was quoted in the Law360 article "New Bill Would Reshape Drug Patent Cases in Uncertain Ways," published on June 14, 2019. In the article, Kevin is quoted as saying that the newly introduced Terminating the Extension of Rights Misappropriated Act, if passed, could "create a second-tier patent right" for patents on a drug beyond the first patent. He emphasizes that beyond patenting a compound, much work is involved in refining that discovery into a consumer product, and that the bill threatens those later innovations.